Abstract
Background: MenAfriVacTM is the first of the World Health Organization (WHO)’s pre-qualified vaccines to be allowed to mass vaccination campaign at a temperature below or equal to 40˚C during 4 days. This new vaccination practice has already been used in some African countries. This article described the opinion and use of this new technique by actors on the field, during a mass vaccination campaign in Côte d’Ivoire, in December 2014. Methods: We conducted a cross-sectional study on the practice of CTC by actors on the field and their perception on the new practice, during a mass vaccination campaign in 2 of 25 health districts in Côte d’Ivoire, in December 2014. Findings: As results, in Séguéla 98.25% of respondents expressed a favourable opinion of CTC, citing advantages such as vaccine carriers requiring no ice packs (29.2%), financial benefit (12.28%) and lighter vaccine carriers (5.26%). In Bouna, respondents gave the same advantages in, respectively, 34%, 2% and 8% of cases...
Cite
CITATION STYLE
Kouassi, D. P., Aka, L. B. N., Bénié, B. V. J., Coulibaly, S. R., Tagodé, D. B., Coulibaly, D., … Ronveaux, O. (2016). Practice of Controlled Temperature Chain (CTC) Technique during a Mass Vaccination Campaign in Côte d’Ivoire. World Journal of Vaccines, 06(01), 16–22. https://doi.org/10.4236/wjv.2016.61003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.